How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield episode artwork

EPISODE · Aug 5, 2025 · 26 MIN

How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield

from Rx for Biotech · host Podcast Host Chris Leidli

Early cancer detection doesn't have to mean invasive tests. In this podcast episode, we sit down with Jeff Bousfield, CEO of Nonacus Cancer Diagnostics, to explore how his UK-based company is revolutionizing precision cancer diagnostics with a powerful suite of non-invasive tools. Jeff shares the human story behind the science and why he believes the future of cancer care starts with precision diagnostics tools that are faster, less invasive, and more accessible to patients.

Episode metadata supplied by the publisher feed · Published Aug 5, 2025

Embed this episode

NOW PLAYING

How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield

0:00 26:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 26 minutes long.

When was this Rx for Biotech episode published?

This episode was published on August 5, 2025.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!